1.Quinn TC. HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS (London, England). 2008;22(Suppl 3):S7.
2.Hull MW, Montaner JS. HIV treatment as prevention: the key to an AIDS-free generation. Journal of food and drug analysis. 2013;21(4):S95-S101.
3.Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, Bennett R, et al. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Current Opinion in HIV and AIDS. 2010;5(4):298.
4.World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva, Switzerland: 2013.
5.Sidibé M, Loures L, Samb B. The UNAIDS 90–90–90 target: a clear choice for ending AIDS and for sustainable health and development. Journal of the International AIDS Society. 2016;19(1):21133.
6.Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A. Can the UNAIDS 90–90–90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Global Health. 2016;1(2):e000010.
7.Zoungrana J et al. Prevalence and Factors Associated with Treatment Failure during Antiretroviral Therapy Atbobo-Dioulasso University Teaching Hospital (Burkina Faso) (2008–2013). Austin J HIV/AIDS Res 2016;3(2).
8.Owusu M, Mensah E, Enimil A, Mutocheluh M. PREVALENCE AND RISK FACTORS OF VIROLOGICAL FAILURE AMONG CHILDREN ON ANTIRETROVIRAL THERAPY. BMJ Global Health. 2017;2(Suppl 2):A9-A.
9.Hawkins C, Ulenga N, Liu E, Aboud S, Mugusi F, Chalamilla G, et al. HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults. Journal of Antimicrobial Chemotherapy. 2016;71(7):1966–74.
10.Yimer YT, Yalew AW. Magnitude and predictors of anti-retroviral treatment (ART) failure in private health facilities in Addis Ababa, Ethiopia. PLoS One. 2015;10(5):e0126026.
11.Hailu GG, Hagos DG, Hagos AK, Wasihun AG, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. PloS one. 2018;13(5):e0196259.
12.Sisay MM, Ayele TA, Gelaw YA, Tsegaye AT, Gelaye KA, Melak MF. Incidence and risk factors of first-line antiretroviral treatment failure among human immunodeficiency virus-infected children in Amhara regional state, Ethiopia: a retrospective follow-up study. BMJ open. 2018;8(4):e019181.
13.Yayehirad AM, Mamo WT, Gizachew AT, Tadesse AA. Rate of immunological failure and its predictors among patients on highly active antiretroviral therapy at Debremarkos hospital, Northwest Ethiopia: a retrospective follow up study. Journal of AIDS and Clinical Research. 2013;4(5).
14.Tsegaye AT, Wubshet M, Awoke T, Alene KA. Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study. BMJ open. 2016;6(12):e012537.
15.Yassin S, Gebretekle GB. Magnitude and predictors of antiretroviral treatment failure among HIV‐infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study. Pharmacology research & perspectives. 2017;5(1):e00296.
16.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS medicine. 2009;6(7):e1000100.
17.Wells GA, Shea, B., O’Connell, D., Peterson, J., Welch, V., et al,. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis 2011.
18.Teshome W, Assefa A. Predictors of immunological failure of antiretroviral therapy among HIV infected patients in Ethiopia: a matched case-control study. PLoS One. 2014;9(12):e115125.
19.Bacha T, Tilahun B, Worku A. Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC infectious diseases. 2012;12(1):197.
20.Sisay C, Bekele A, Sisay A, Mekonen H, Terfa K. Incidence and Predictors of Anti-Retroviral Treatment (ART) Failure among Adults Receiving HIV Care at Zewditu Memorial Hospital, Addis Ababa, Ethiopia. J AIDS Clin Res. 2017;8(749):2.
21.Getnet Y. Determinants of First Line Antiretroviral Treatment Failure in Public Hospitals of Addis Ababa, Ethiopia: Unmatched Case Control Study. Journal of Biology, Agriculture and Healthcare. 2014;4(224–3208):1–12.
22.Abdissa A, Yilma D, Fonager J, Audelin AM, Christensen LH, Olsen MF, et al. Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia. BMC infectious diseases. 2014;14(1):181.
23.Workneh N, Girma T, Woldie M. Immunologic and clinical outcomes of children on HAART: a Retrospective cohort analysis at Jimma University specialized hospital. Ethiopian Journal of Health Sciences. 2009;19(2).
24.Tadesse BT, Foster BA, Jerene D, Ruff A. Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia. BMJ open. 2017;7(2):e013528.
25.Babo YD, Alemie GA, Fentaye FW. Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. PloS one. 2017;12(11):e0187694.
26.Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case-control study. HIV/AIDS (Auckland, NZ). 2017;9:153–9.
27.Bokretsion GB, Endalkachew N, Getachew KA. HIV/AIDS treatment failure and its determinant factors among first line HAART patients at Felege-Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia. Journal of AIDS and Clinical Research. 2017;8(11).
28.Zeleke A. Prevalence of antiretroviral treatment failure and associated factors in HIV infected children on antiretroviral therapy at Gondar University Hospital, retrospective cohort study. International Journal of Medicine and Medical Sciences. 2016;8(11):125–32.
29.Ayalew MB, Kumilachew D, Belay A, Getu S, Teju D, Endale D, et al. First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. HIV/AIDS (Auckland, NZ). 2016;8:141.
30.Deribew A, Biadgilign S, Berhanu D, Defar A, Deribe K, Tekle E, et al. Capacity of health facilities for diagnosis and treatment of HIV/AIDS in Ethiopia. BMC health services research. 2018;18(1):535.
31.Nash D, Tymejczyk O, Gadisa T, Kulkarni SG, Hoffman S, Yigzaw M, et al. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013. Journal of the International AIDS Society. 2016;19(1):20637.
32.Haileamlak A, Hagos T, Abebe W, Abraham L, Asefa H, Teklu AM. Predictors of Hospitalization among Children on ART in Ethiopia: a Cohort study. Ethiopian journal of health sciences. 2017;27(1):53–62.
33.Gebremichael DY, Hadush KT, Kebede EM, Zegeye RT. Food Insecurity, Nutritional Status, and Factors Associated with Malnutrition among People Living with HIV/AIDS Attending Antiretroviral Therapy at Public Health Facilities in West Shewa Zone, Central Ethiopia. BioMed research international. 2018;2018.
34.Abdissa S, Fekade D, Feleke Y, Seboxa T, Diro E. Adverse drug reactions associated with antiretroviral treatment among adult Ethiopian patients in a tertiary hospital. Ethiopian medical journal. 2012;50(2):107–13.
35.Selamawit Z, Nurilign A. Common mental disorder among HIV infected individuals at Comprehensive HIV Care and Treatment Clinic of Debre Markos referral Hospital, Ethiopia. Journal of AIDS and Clinical Research. 2015;6(2).
36.Amare T, Getinet W, Shumet S, Asrat B. Prevalence and Associated Factors of Depression among PLHIV in Ethiopia: Systematic Review and Meta-Analysis, 2017. AIDS research and treatment. 2018;2018.
37.Le NK, Riggi E, Marrone G, Van Vu T, Izurieta RO, Nguyen CKT, et al. Assessment of WHO criteria for identifying ART treatment failure in Vietnam from 2007 to 2011. PloS one. 2017;12(9):e0182688.
38.Westley BP, DeLong AK, Tray CS, Sophearin D, Dufort EM, Nerrienet E, et al. Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children. Clinical Infectious Diseases. 2012;55(3):432–40.
39.Khienprasit N, Chaiwarith R, Sirisanthana T, Supparatpinyo K. Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, Thailand. AIDS research and therapy. 2011;8(1):42.
40.Soria A, Porten K, Fampou-Toundji J, Galli L, Mougnutou R, Buard V, et al. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type–1-infected patients. Antiviral therapy. 2009.
41.Okoye AA, Picker LJ. CD 4+ T‐cell depletion in HIV infection: mechanisms of immunological failure. Immunological reviews. 2013;254(1):54–64.
42.Endalamaw A, Tezera N, Eshetie S, Ambachew S, Habtewold TD. Adherence to Highly Active Antiretroviral Therapy Among Children in Ethiopia: A Systematic Review and Meta-analysis. AIDS and Behavior. 2018:1–11.
43.Giday A, Shiferaw W. Factors affecting adherence of antiretroviral treatment among AIDS patients in an Ethiopian tertiary university teaching hospital. Ethiopian medical journal. 2010;48(3):187–94.
44.Markos E, Worku A, Davey G. Adherence to ART in PLWHA and Yirgalem Hospital, South Ethiopia. Ethiopian Journal of Health Development. 2008;22(2):174–9.